Subscribe To
VRAY / ViewRay, Inc.'s (VRAY) CEO Scott Drake on Q1 2022 Results - Earnings Call Transcript
VRAY News
By InvestorPlace
July 17, 2023
Why Is ViewRay (VRAY) Stock Down 69% Today?
ViewRay (NASDAQ: VRAY ) stock is falling hard on Monday after the MRI company announced its voluntary Chapter 11 bankruptcy filing! According to the c more_horizontal
By Zacks Investment Research
May 10, 2023
ViewRay (VRAY) Reports Q1 Loss, Misses Revenue Estimates
ViewRay (VRAY) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.1 more_horizontal
By Seeking Alpha
April 13, 2023
ViewRay: Shares Crater As Company Warns Of Slower Growth, Higher Cash Burn
Magnetic resonance imaging-guided radiation therapy system provider ViewRay, Inc. has shocked investors with a severe revenue and cash flow warning. more_horizontal
By PRNewsWire
April 12, 2023
ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023
DENVER , April 12, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) will hold a conference call to discuss results on Thursday, April 13 more_horizontal
By Seeking Alpha
February 27, 2023
ViewRay, Inc. (VRAY) Q4 2022 Earnings Call Transcript
ViewRay, Inc. (NASDAQ:VRAY ) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Participants Matt Harrison - Director of IR Scott D more_horizontal
By Zacks Investment Research
February 27, 2023
ViewRay (VRAY) Reports Q4 Loss, Misses Revenue Estimates
ViewRay (VRAY) delivered earnings and revenue surprises of 6.25% and 0.71%, respectively, for the quarter ended December 2022. Do the numbers hold clu more_horizontal
By Seeking Alpha
February 12, 2023
ViewRay: Sales, Order Momentum Ratcheting Higher
ViewRay has continued growth in order momentum. Its stock price has moved sideways into the new year, adding another attractive entry point. more_horizontal
By Seeking Alpha
November 24, 2022
ViewRay: Revise Thesis To Buy, Multiple Upside Targets In Place
Revised FY22 revenue guidance with management more confident on the lower end of range. Backlog continues to grow, ending 26% higher to $350mm for the more_horizontal